These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22965278)

  • 1. Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds.
    Sabalza M; Madeira L; van Dolleweerd C; Ma JK; Capell T; Christou P
    Plant Mol Biol; 2012 Nov; 80(4-5):477-88. PubMed ID: 22965278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.
    Rosenberg Y; Sack M; Montefiori D; Forthal D; Mao L; Hernandez-Abanto S; Urban L; Landucci G; Fischer R; Jiang X
    PLoS One; 2013; 8(3):e58724. PubMed ID: 23533588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.
    Wolbank S; Kunert R; Stiegler G; Katinger H
    J Virol; 2003 Apr; 77(7):4095-103. PubMed ID: 12634368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).
    Joos B; Trkola A; Kuster H; Aceto L; Fischer M; Stiegler G; Armbruster C; Vcelar B; Katinger H; Günthard HF
    Antimicrob Agents Chemother; 2006 May; 50(5):1773-9. PubMed ID: 16641449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.
    Mascola JR; Louder MK; VanCott TC; Sapan CV; Lambert JS; Muenz LR; Bunow B; Birx DL; Robb ML
    J Virol; 1997 Oct; 71(10):7198-206. PubMed ID: 9311792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans.
    Rademacher T; Sack M; Arcalis E; Stadlmann J; Balzer S; Altmann F; Quendler H; Stiegler G; Kunert R; Fischer R; Stoger E
    Plant Biotechnol J; 2008 Feb; 6(2):189-201. PubMed ID: 17979949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint.
    Ho J; MacDonald KS; Barber BH
    Vaccine; 2002 Jan; 20(7-8):1169-80. PubMed ID: 11803079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.
    Quakkelaar ED; van Alphen FP; Boeser-Nunnink BD; van Nuenen AC; Pantophlet R; Schuitemaker H
    J Virol; 2007 Aug; 81(16):8533-42. PubMed ID: 17522228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and application of benzyl-sulfonate biomimetic affinity adsorbents for monoclonal antibody purification from transgenic corn.
    Maltezos A; Platis D; Vlachakis D; Kossida S; Marinou M; Labrou NE
    J Mol Recognit; 2014 Jan; 27(1):19-31. PubMed ID: 24375581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity chromatography for the purification of therapeutic proteins from transgenic maize using immobilized histamine.
    Platis D; Labrou NE
    J Sep Sci; 2008 Mar; 31(4):636-45. PubMed ID: 18307162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.
    Zhu Z; Qin HR; Chen W; Zhao Q; Shen X; Schutte R; Wang Y; Ofek G; Streaker E; Prabakaran P; Fouda GG; Liao HX; Owens J; Louder M; Yang Y; Klaric KA; Moody MA; Mascola JR; Scott JK; Kwong PD; Montefiori D; Haynes BF; Tomaras GD; Dimitrov DS
    J Virol; 2011 Nov; 85(21):11401-8. PubMed ID: 21880764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12.
    Shcherbakova NS; Chikaev AN; Rudometov AP; Shcherbakov DN; Il'ichev AA; Karpenko LI
    Bull Exp Biol Med; 2019 Jun; 167(2):259-262. PubMed ID: 31243678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
    Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
    J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.
    Stiegler G; Kunert R; Purtscher M; Wolbank S; Voglauer R; Steindl F; Katinger H
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1757-65. PubMed ID: 11788027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
    Li A; Baba TW; Sodroski J; Zolla-Pazner S; Gorny MK; Robinson J; Posner MR; Katinger H; Barbas CF; Burton DR; Chou TC; Ruprecht RM
    AIDS Res Hum Retroviruses; 1997 May; 13(8):647-56. PubMed ID: 9168233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.
    Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF
    J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms.
    Niemer M; Mehofer U; Torres Acosta JA; Verdianz M; Henkel T; Loos A; Strasser R; Maresch D; Rademacher T; Steinkellner H; Mach L
    Biotechnol J; 2014 Apr; 9(4):493-500. PubMed ID: 24478053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody.
    Floss DM; Sack M; Arcalis E; Stadlmann J; Quendler H; Rademacher T; Stoger E; Scheller J; Fischer R; Conrad U
    Plant Biotechnol J; 2009 Dec; 7(9):899-913. PubMed ID: 19843249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
    Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.
    Yuste E; Sanford HB; Carmody J; Bixby J; Little S; Zwick MB; Greenough T; Burton DR; Richman DD; Desrosiers RC; Johnson WE
    J Virol; 2006 Mar; 80(6):3030-41. PubMed ID: 16501112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.